This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tapper, J. Articles by Butzow, R. Search for Related Content PubMed Articles by Tapper, J. Articles by Butzow, R.

Genetic Changes in Inherited and Sporadic Ovarian Carcinomas by Comparative Genomic Hybridization: Extensive Similarity Except for a Difference at Chromosome 2q24–q32¹

Departments of Obstetrics and Gynecology [J. T., L. S., P. V., H. N., M. S., R. B.], Oncology [S. H.], and Pathology [R. B.], Helsinki University Central Hospital, 00290 Helsinki, and Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, 00014, Helsinki [S. K.], Finland

Germ-line mutations in the BRCA1 and BRCA2 genes confer a predisposition to breast as well as ovarian carcinoma. Except for loss of the respective wild-type allele, somatic genetic changes needed for the progression of inherited ovarian tumors are unknown. A genome-wide search for such alterations was performed by comparative genomic hybridization analysis on BRCA1 and BRCA2 mutation-positive (n = 20) ovarian carcinoma specimens. Comparison with sporadic ovarian carcinomas (n = 20) revealed extensive genetic similarity between the inherited and sporadic carcinomas with the sole exception of a frequent gain of 2q24–q32 in the inherited group, suggesting the presence of an oncogene at 2q24–q32 operating in the absence of BRCA1 function. The overall similarity of gains and losses by comparative genomic hybridization suggests a common main pathway in tumor progression of both inherited and sporadic ovarian carcinomas.

¹ Supported by grants from the Helsinki University Central Hospital Research Fund and the Helsingin Sanomat Fund.

² To whom requests for reprints should be addressed, at Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Haartmaninkatu 2, 00290 Helsinki, Finland. Phone: 358-09-4714912; Fax: 358-09-4714801; E-mail: ralf.butzow@huch.fi.

Received 3/ 3/98. Accepted 5/15/98.

This article has been cited by other articles:

				R. A. DiCioccio, H. Song, C. Waterfall, M. T. Kimura, H. Nagase, V. McGuire, E. Hogdall, M. N. Shah, R. N. Luben, D. F. Easton, et al. STK15 Polymorphisms and Association with Risk of Invasive Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1589 - 1594. [Abstract] [Full Text] [PDF]

				T.-L. Erkinheimo, H. Lassus, P. Finne, B. P. van Rees, A. Leminen, O. Ylikorkala, C. Haglund, R. Butzow, and A. Ristimaki Elevated Cyclooxygenase-2 Expression Is Associated with Altered Expression of p53 and SMAD4, Amplification of HER-2/neu, and Poor Outcome in Serous Ovarian Carcinoma Clin. Cancer Res., January 15, 2004; 10(2): 538 - 545. [Abstract] [Full Text] [PDF]

				S. J. Ramus, P. D. P. Pharoah, P. Harrington, C. Pye, B. Werness, L. Bobrow, A. Ayhan, D. Wells, A. Fishman, M. Gore, et al. BRCA1/2 Mutation Status Influences Somatic Genetic Progression in Inherited and Sporadic Epithelial Ovarian Cancer Cases Cancer Res., January 15, 2003; 63(2): 417 - 423. [Abstract] [Full Text] [PDF]

				J. Bayani, J. D. Brenton, P. F. Macgregor, B. Beheshti, M. Albert, D. Nallainathan, J. Karaskova, B. Rosen, J. Murphy, S. Laframboise, et al. Parallel Analysis of Sporadic Primary Ovarian Carcinomas by Spectral Karyotyping, Comparative Genomic Hybridization, and Expression Microarrays Cancer Res., June 1, 2002; 62(12): 3466 - 3476. [Abstract] [Full Text] [PDF]

				H. Lassus, R. Salovaara, L. A. Aaltonen, and R. Butzow Allelic Analysis of Serous Ovarian Carcinoma Reveals Two Putative Tumor Suppressor Loci at 18q22-q23 Distal to SMAD4, SMAD2, and DCC Am. J. Pathol., July 1, 2001; 159(1): 35 - 42. [Abstract] [Full Text] [PDF]

				R. S. Ismail, R. L. Baldwin, J. Fang, D. Browning, B. Y. Karlan, J. C. Gasson, and D. D. Chang Differential Gene Expression between Normal and Tumor-derived Ovarian Epithelial Cells Cancer Res., December 1, 2000; 60(23): 6744 - 6749. [Abstract] [Full Text]

				R. G. Weber, T. Pietsch, D. von Schweinitz, and P. Lichter Characterization of Genomic Alterations in Hepatoblastomas : A Role for Gains on Chromosomes 8q and 20 as Predictors of Poor Outcome Am. J. Pathol., August 1, 2000; 157(2): 571 - 578. [Abstract] [Full Text] [PDF]

				J. Boyd, Y. Sonoda, M. G. Federici, F. Bogomolniy, E. Rhei, D. L. Maresco, P. E. Saigo, L. A. Almadrones, R. R. Barakat, C. L. Brown, et al. Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer JAMA, May 3, 2000; 283(17): 2260 - 2265. [Abstract] [Full Text] [PDF]

				M. M. Tanner, S. Grenman, A. Koul, O. Johannsson, P. Meltzer, T. Pejovic, A. Borg, and J. J. Isola Frequent Amplification of Chromosomal Region 20q12-q13 in Ovarian Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1833 - 1839. [Abstract] [Full Text] [PDF]

				J. Gogusev, J. B. de Joliniere, L. Telvi, M. Doussau, A. Stojkoski, and M. Levradon Cellular and Genetic Constitution of Human Endometriosis Tissues Reproductive Sciences, March 1, 2000; 7(2): 79 - 87. [Abstract] [PDF]

				S. Hemmer, V.-M. Wasenius, S. Knuutila, K. Franssila, and H. Joensuu DNA Copy Number Changes in Thyroid Carcinoma Am. J. Pathol., May 1, 1999; 154(5): 1539 - 1547. [Abstract] [Full Text] [PDF]

				L. Du Plessis, E. Dietzsch, M. Van Gele, N. Van Roy, P. Van Helden, M. I. Parker, D. K. Mugwanya, M. De Groot, M. P. Marx, M. J. Kotze, et al. Mapping of Novel Regions of DNA Gain and Loss by Comparative Genomic Hybridization in Esophageal Carcinoma in the Black and Colored Populations of South Africa Cancer Res., April 1, 1999; 59(8): 1877 - 1883. [Abstract] [Full Text] [PDF]